Kiora Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Kiora Pharmaceuticals Inc share price today is $2.06, up 2.96%. The stock opened at $2.02 against the previous close of $2.03, with an intraday high of $2.06 and low of $2.01.
Kiora Pharmaceuticals Inc Share Price Chart
Kiora Pharmaceuticals Inc
Kiora Pharmaceuticals Inc Share Price Performance
Kiora Pharmaceuticals Inc Institutional Holdings
Kiora Pharmaceuticals Inc Market Status
Kiora Pharmaceuticals Inc Fundamentals
Market Cap 7.69 M
PB Ratio 0.343
PE Ratio 0.0
Enterprise Value -11.28 M
Total Assets 36.48 M
Volume 55742
Kiora Pharmaceuticals Inc Company Financials
About Kiora Pharmaceuticals Inc & investment objective
Company Information Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301; and collaboration and development agreement with Global Genes for treating rare ocular disorders. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Organisation Biotechnology
Employees 12
Industry Biotechnology
CEO Dr. Brian M. Strem Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Kiora Pharmaceuticals Inc FAQs
What is the share price of Kiora Pharmaceuticals Inc today?
The current share price of Kiora Pharmaceuticals Inc is $2.06.
Can I buy Kiora Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Kiora Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Kiora Pharmaceuticals Inc shares in India?
You can easily invest in Kiora Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Kiora Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Kiora Pharmaceuticals Inc.
Can I buy fractional shares of Kiora Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Kiora Pharmaceuticals Inc?
Kiora Pharmaceuticals Inc has a market cap of $7.69 M.
In which sector does Kiora Pharmaceuticals Inc belong?
Kiora Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Kiora Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Kiora Pharmaceuticals Inc?
The PE ratio of Kiora Pharmaceuticals Inc is N/A and the PB ratio is 0.34.